DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C0153405 | Malignant neoplasm of pharynx | CYP2E1 | 1571 | cytochrome P450 family 2 subfamily E member 1 | P05181 |
C0394005 | Ataxic cerebral palsy | CYP2E1 | 1571 | cytochrome P450 family 2 subfamily E member 1 | P05181 |
C0018802 | Congestive heart failure | CYP2E1 | 1571 | cytochrome P450 family 2 subfamily E member 1 | P05181 |
C0023532 | Leukoplakia, Oral | CYP2E1 | 1571 | cytochrome P450 family 2 subfamily E member 1 | P05181 |
C0272170 | Shwachman syndrome | CYP2E1 | 1571 | cytochrome P450 family 2 subfamily E member 1 | P05181 |
C0040332 | Tobacco Dependence | CYP2E1 | 1571 | cytochrome P450 family 2 subfamily E member 1 | P05181 |
C0079740 | High Grade Lymphoma (neoplasm) | CYP2E1 | 1571 | cytochrome P450 family 2 subfamily E member 1 | P05181 |
C0026848 | Myopathy | CYP2E1 | 1571 | cytochrome P450 family 2 subfamily E member 1 | P05181 |
C1862389 | ATRIAL SEPTAL DEFECT 1 | CYP2E1 | 1571 | cytochrome P450 family 2 subfamily E member 1 | P05181 |
C3463824 | MYELODYSPLASTIC SYNDROME | CYP2E1 | 1571 | cytochrome P450 family 2 subfamily E member 1 | P05181 |
C0024306 | Lymphoma, Undifferentiated | CYP2E1 | 1571 | cytochrome P450 family 2 subfamily E member 1 | P05181 |
C0241910 | Autoimmune Chronic Hepatitis | CYP2E1 | 1571 | cytochrome P450 family 2 subfamily E member 1 | P05181 |
C0003431 | Antisocial Personality Disorder | CYP2E1 | 1571 | cytochrome P450 family 2 subfamily E member 1 | P05181 |
C0205642 | Adenocarcinoma, Oxyphilic | CYP2E1 | 1571 | cytochrome P450 family 2 subfamily E member 1 | P05181 |
C0751494 | Convulsive Seizures | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0220743 | Childhood hypophosphatasia (disorder) | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0020630 | Hypophosphatasia | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0520739 | Hereditary pyropoikilocytosis | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0001787 | Osteoporosis, Age-Related | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0268413 | Adult hypophosphatasia (disorder) | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0004153 | Atherosclerosis | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0268412 | Infantile hypophosphatasia | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0494475 | Tonic - clonic seizures | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0751495 | Seizures, Focal | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0011334 | Dental caries | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024